KYNTRA BIO, INC. (KYNB) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for KYNTRA BIO, INC.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, KYNTRA BIO, INC.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does KYNTRA BIO, INC. actually do?
Answer:
Kyntra Bio, Inc. is a biopharmaceutical company focused on developing novel therapies for cancer and anemia, recently rebranding from FibroGen, Inc. The company is advancing FG-3246, an antibody-drug conjugate targeting CD46 for metastatic castration-resistant prostate cancer (mCRPC), alongside a companion PET imaging agent, FG-3180. Kyntra Bio also continues development of roxadustat for anemia associated with lower-risk myelodysplastic syndromes (MDS), having previously partnered on its approval for anemia in chronic kidney disease patients in Europe, Japan, and China. In August 2025, the company completed the sale of its China operations to AstraZeneca, retaining rights to roxadustat in the U.S., Canada, Mexico, and other markets not licensed to Astellas.
Question:
What are KYNTRA BIO, INC.'s revenue drivers?
Answer:
Revenue is primarily driven by collaboration agreements, including milestone payments, development services, and sales of bulk drug product (API) to partners like Astellas. The company also generates revenue from roxadustat product sales in territories where it retains rights.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required